Cargando…
Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report
Primary squamous cell carcinoma of the breast is a rare subtype of carcinoma of chemosis for which there is no effective chemotherapy regimen. Breast squamous cell carcinoma is usually “triple negative”, with poor chemotherapy effects and poor prognosis. Here, we report a successful case of primary...
Autores principales: | Gao, Fangfang, Li, Jingtai, Liao, Haoran, Fan, Pingming, Wang, Minjian, Liu, Yu, Ding, Linwei, Du, Guankui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213914/ https://www.ncbi.nlm.nih.gov/pubmed/37251309 http://dx.doi.org/10.3389/fphar.2023.1115422 |
Ejemplares similares
-
Acute thrombocytopenia induced by trastuzumab due to complement reaction: A case report
por: Chen, Guoping, et al.
Publicado: (2022) -
The Effect of Whole-Grain Diet on the Gut Microbiota of the Elderly Individuals
por: Cui, Zeying, et al.
Publicado: (2022) -
Preoperative neoadjuvant targeted therapy with apatinib for inoperable differentiated thyroid cancer: A case report
por: Zhang, Yingchao, et al.
Publicado: (2021) -
Adding of apatinib and camrelizumab to overcome de novo trastuzumab resistance of HER2-positive gastric cancer: A case report and literature review
por: Lv, Huifang, et al.
Publicado: (2023) -
Apatinib Combined With SOX Regimen in Conversion Treatment of Advanced Gastric Cancer: A Case Series and Literature Review
por: Jiang, Dingyi, et al.
Publicado: (2020)